Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

Hiroji Iwata, Norikazu Masuda, Yutaka Yamamoto, +19

Breast Cancer Research and Treatment

NRF2 immunolocalization in human breast cancer patients as a prognostic factor

Yoshiaki Onodera, Hozumi Motohashi, Kiyoshi Takagi, +8

Endocrine Related Cancer

Aromatase inhibitor treatment of breast cancer cells increases the expression of <i>let‐7f</i> , a microRNA targeting <i>CYP19A1</i>

Yukiko Shibahara, Yasuhiro Miki, Yoshiaki Onodera, +13

The Journal of Pathology

LIN28: A regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer

Minako Sakurai, Yasuhiro Miki, Mariko Masuda, +5

The Journal of Steroid Biochemistry and Molecular Biology

Tumor BiologyLet-7 MicrornaTumor-suppressing ActivityCancer Cell BiologyHuman Breast Cancer +9

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy

Ichiyo Shibahara, Ryuta Saito, Rong Zhang, +16

Molecular Cancer

Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer

Arushi Jaiswal, Kiichi Murakami, Andrew Elia, +6

Proceedings of the National Academy of Sciences

Amyloid precursor protein in human breast cancer: An androgen‐induced gene associated with cell proliferation

Kiyoshi Takagi, Shigehiro Ito, Toshiaki Miyazaki, +7

Cancer Science

Increased androgen receptor activity and cell proliferation in aromatase inhibitor-resistant breast carcinoma

Rika Fujii, Toru Hanamura, Takashi Suzuki, +10

The Journal of Steroid Biochemistry and Molecular Biology

Androgen Receptor ActivityBreast OncologyMedicineHormonal ReceptorCell Proliferation +9

BUB1 Immunolocalization in Breast Carcinoma: Its Nuclear Localization as a Potent Prognostic Factor of the Patients

Kiyoshi Takagi, Yasuhiro Miki, Yukiko Shibahara, +6

Hormones and Cancer

Breast OncologyMedicineImmunologyPathologyImmune Checkpoint Inhibitor +6

Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes

Keely May McNamara, Tomomi Yoda, Alif Meem Nurani, +16

Breast Cancer Research and Treatment

Breast OncologyMedicinePathologyBreast CancerAndrogenic Pathways +5